[A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors and metabolic syndrome].

K. Sanada,M. Iemitsu,I. Tabata,M. Miyachi,H. Murakami,Kenta Yamamoto,S. Hanawa,R. Kawakami,H. Kawano,Y. Gando,Katsuhiko Suzuki,M. Higuchi,Michiya Tanimoto,Yumi Omori

DOI: https://doi.org/10.3143/GERIATRICS.49.715

Abstract:

What problem does this paper attempt to address?

Neonatal seizures and status epilepticus

Nicholas S Abend,Courtney J Wusthoff

DOI: https://doi.org/10.1097/WNP.0b013e31826bd90d

Abstract:Neonatal seizures are common, often require EEG monitoring for diagnosis and management, may be associated with worse neurodevelopmental outcome, and can often be treated with existing anticonvulsants. A neonatal electrographic seizure is defined as a sudden, repetitive, evolving, and stereotyped event of abnormal electrographic pattern with amplitude of at least 2 μV and a minimum duration of 10 seconds. The diagnosis of neonatal seizures relies heavily on the neurophysiologist's interpretation of EEG. Consideration of specific criteria for the definition of a neonatal seizure, including seizure duration, location, morphology, evolution, semiology, and overall seizure burden, has utility for both the clinician and the researcher. The importance of EEG in the diagnosis and management of neonatal seizures, the electrographic characteristics of neonatal seizures, the impact of neonatal seizures on outcome, and tools to aid in the identification of neonatal seizures are reviewed.
New treatment paradigms in neonatal metabolic epilepsies

P L Pearl

DOI: https://doi.org/10.1007/s10545-009-1045-8

Abstract:Neonatal seizures represent a major challenge among the epilepsies vis-à-vis seizure classification, electroclinical correlation, inherent excitability of neocortex, ontogenic characteristics of neurotransmitter receptors, and responsiveness to standard antiepileptic drugs. Each of these factors renders neonatal seizures more difficult to treat, and therapy has been a vexing area for recent advances in this seizure category. Conversely, specific metabolic disorders have very special therapeutic considerations in the clinical setting of neonatal seizures which require a high index of clinical suspicion and rapid intervention for a successful outcome. The prototype is pyridoxine dependency, although pyridoxal 5'-phosphate dependency is a recently recognized but treatable neonatal epilepsy that deserves earmarked distinction. Clinicians must remain vigilant for these possibilities, including atypical cases where apparent seizure-free intervals may occur. Folinic acid-dependent seizures are allelic with pyridoxine dependency. Serine-dependent seizures and glucose transporter deficiency may present with neonatal seizures and have specific therapy. A vital potassium channel regulated by serum ATP/ADP ratios in the pancreas and brain may be mutated with a resultant neuroendocrinopathy characterized by development delay, epilepsy, and neonatal diabetes (DEND). This requires oral hypoglycaemic therapy, and not insulin, for neurological responsiveness. The startle syndrome of hyperekplexia, which mimics neonatal epilepsy, has been associated with laryngospasm and sudden death but is treated with benzodiazepines.
Developmental and epileptic encephalopathies

Ingrid E Scheffer,Sameer Zuberi,Heather C Mefford,Renzo Guerrini,Amy McTague

DOI: https://doi.org/10.1038/s41572-024-00546-6

2024-09-05

Abstract:Developmental and epileptic encephalopathies, the most severe group of epilepsies, are characterized by seizures and frequent epileptiform activity associated with developmental slowing or regression. Onset typically occurs in infancy or childhood and includes many well-defined epilepsy syndromes. Patients have wide-ranging comorbidities including intellectual disability, psychiatric features, such as autism spectrum disorder and behavioural problems, movement and musculoskeletal disorders, gastrointestinal and sleep problems, together with an increased mortality rate. Problems change with age and patients require substantial support throughout life, placing a high psychosocial burden on parents, carers and the community. In many patients, the aetiology can be identified, and a genetic cause is found in >50% of patients using next-generation sequencing technologies. More than 900 genes have been identified as monogenic causes of developmental and epileptic encephalopathies and many cell components and processes have been implicated in their pathophysiology, including ion channels and transporters, synaptic proteins, cell signalling and metabolism and epigenetic regulation. Polygenic risk score analyses have shown that common variants also contribute to phenotypic variability. Holistic management, which encompasses antiseizure therapies and care for multimorbidities, is determined both by epilepsy syndrome and aetiology. Identification of the underlying aetiology enables the development of precision medicines to improve the long-term outcome of patients with these devastating diseases.
Recent Advances in the Diagnosis and Treatment of Neonatal Seizures

Debopam Samanta

DOI: https://doi.org/10.1055/s-0040-1721702

2020-12-08

Neuropediatrics

Abstract:Abstract Seizures are the most common neurological emergency in the neonates, and this age group has the highest incidence of seizures compared with any other period of life. The author provides a narrative review of recent advances in the genetics of neonatal epilepsies, new neonatal seizure classification system, diagnostics, and treatment of neonatal seizures based on a comprehensive literature review (MEDLINE using PubMED and OvidSP vendors with appropriate keywords to incorporate recent evidence), personal practice, and experience. Knowledge regarding various systemic and postzygotic genetic mutations responsible for neonatal epilepsy has been exploded in recent times, as well as better delineation of clinical phenotypes associated with rare neonatal epilepsies. An International League Against Epilepsy task force on neonatal seizure has proposed a new neonatal seizure classification system and also evaluated the specificity of semiological features related to particular etiology. Although continuous video electroencephalogram (EEG) is the gold standard for monitoring neonatal seizures, amplitude-integrated EEGs have gained significant popularity in resource-limited settings. There is tremendous progress in the automated seizure detection algorithm, including the availability of a fully convolutional neural network using artificial machine learning (deep learning). There is a substantial need for ongoing research and clinical trials to understand optimal medication selection (first line, second line, and third line) for neonatal seizures, treatment duration of antiepileptic drugs after cessation of seizures, and strategies to improve neuromorbidities such as cerebral palsy, epilepsy, and developmental impairments. Although in recent times, levetiracetam use has been significantly increased for neonatal seizures, a multicenter, randomized, blinded, controlled phase IIb trial confirmed the superiority of phenobarbital over levetiracetam in the acute suppression of neonatal seizures. While there is no single best choice available for the management of neonatal seizures, institutional guidelines should be formed based on a consensus of local experts to mitigate wide variability in the treatment and to facilitate early diagnosis and treatment.

pediatrics,clinical neurology
ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions

Sameer M. Zuberi,Elaine Wirrell,Elissa Yozawitz,Jo M. Wilmshurst,Nicola Specchio,Kate Riney,Ronit Pressler,Stephane Auvin,Pauline Samia,Edouard Hirsch,Santiago Galicchio,Chahnez Triki,O. Carter Snead,Samuel Wiebe,J. Helen Cross,Paolo Tinuper,Ingrid E. Scheffer,Emilio Perucca,Solomon L. Moshé,Rima Nabbout

DOI: https://doi.org/10.1111/epi.17239

IF: 6.74

2022-05-05

Epilepsia

Abstract:The International League Against Epilepsy (ILAE) Task Force on Nosology and Definitions proposes a classification and definition of epilepsy syndromes in the neonate and infant with seizure onset up to 2 years of age. The incidence of epilepsy is high in this age group and epilepsy is frequently associated with significant comorbidities and mortality. The licensing of syndrome specific antiseizure medications following randomized controlled trials and the development of precision, gene‐related therapies are two of the drivers defining the electroclinical phenotypes of syndromes with onset in infancy. The principal aim of this proposal, consistent with the 2017 ILAE Classification of the Epilepsies, is to support epilepsy diagnosis and emphasize the importance of classifying epilepsy in an individual both by syndrome and etiology. For each syndrome, we report epidemiology, clinical course, seizure types, electroencephalography (EEG), neuroimaging, genetics, and differential diagnosis. Syndromes are separated into self‐limited syndromes, where there is likely to be spontaneous remission and developmental and epileptic encephalopathies, diseases where there is developmental impairment related to both the underlying etiology independent of epileptiform activity and the epileptic encephalopathy. The emerging class of etiology‐specific epilepsy syndromes, where there is a specific etiology for the epilepsy that is associated with a clearly defined, relatively uniform, and distinct clinical phenotype in most affected individuals as well as consistent EEG, neuroimaging, and/or genetic correlates, is presented. The number of etiology‐defined syndromes will continue to increase, and these newly described syndromes will in time be incorporated into this classification. The tables summarize mandatory features, cautionary alerts, and exclusionary features for the common syndromes. Guidance is given on the criteria for syndrome diagnosis in resource‐limited regions where laboratory confirmation, including EEG, MRI, and genetic testing, might not be available.

clinical neurology
Neonatal seizures as onset of Inborn Errors of Metabolism (IEMs): from diagnosis to treatment. A systematic review

Raffaele Falsaperla,Laura Sciuto,Luisa La Spina,Sarah Sciuto,Andrea D Praticò,Martino Ruggieri

DOI: https://doi.org/10.1007/s11011-021-00798-1

Abstract:Neonatal seizures (NS) occur in the first 28 days of life; they represent an important emergency that requires a rapid diagnostic work-up to start a prompt therapy. The most common causes of NS include: intraventricular haemorrhage, hypoxic-ischemic encephalopathy, hypoglycemia, electrolyte imbalance, neonatal stroke or central nervous system infection. Nevertheless, an Inborn Error of Metabolism (IEM) should be suspected in case of NS especially if these are resistant to common antiseizure drugs (ASDs) and with metabolic decompensation. Nowadays, Expanded Newborn Screening (ENS) has changed the natural history of some IEMs allowing a rapid diagnosis and a prompt onset of specific therapy; nevertheless, not all IEMs are detected by such screening (e.g. Molybdenum-Cofactor Deficiency, Hypophosphatasia, GLUT1-Deficiency Syndrome) and for this reason neonatologists have to screen for these diseases in the diagnostic work-up of NS. For IEMs, there are not specific semiology of seizures and EEG patterns. Herein, we report a systematic review on those IEMs that lead to NS and epilepsy in the neonatal period, studying only those IEMs not included in the ENS with tandem mass, suggesting clinical, biochemical features, and diagnostic work-up. Remarkably, we have observed a worse neurological outcome in infants undergoing only a treatment with common AED for their seizures, in comparison to those primarily treated with specific anti-convulsant treatment for the underlying metabolic disease (e.g.Ketogenic Diet, B6 vitamin). For this reason, we underline the importance of an early diagnosis in order to promptly intervene with a targeted treatment without waiting for drug resistance to arise.
Genotypes and Clinical Features of Neonatal-Onset Genetic Epilepsy in 141 Patients

J Y Chen,Y Yang,X Y Niu,J Zhang,Y Chen,X L Yang,Z X Yang,Y W Jiang,Y H Zhang

DOI: https://doi.org/10.3760/cma.j.cn112140-20210206-00113

2021-01-01

Abstract:Objective:To summarize the genotypes and clinical features of neonatal-onset genetic epilepsy.Methods:Patients (114 cases) with identified gene variants were collected from May 2013 to May 2019 in Peking University First Hospital, retrospectively. The genotype, clinical, electroencephalographic and neuroimaging characteristics were analyzed.Results:A total of 141 neonatal-onset epilepsy patients with identified gene variants were enrolled, including 76 males and 65 females and involving 33 epilepsy genes. Top five genes were KCNQ2 (56 cases), SCN2A (25 cases), STXBP1 (9 cases), CDKL5 (8 cases) and KCNT1 (6 cases), accounting for 73.8% (104/141). The age of seizure onset was 3(1-28) days of age, 71.6% (101/141) were within 1 week of age. The age of genetic diagnosis was 4 months (1 month to 13 years) of age. A total of 130 patients presented focal seizures; 47 patients presented epileptic spasms. Other seizure types included generalized tonic-clonic seizures, clonic seizures, myoclonic seizures, tonic seizures and absence seizures. Fifty-eight patients experienced multiple seizure types. The results of video-electroencephlogram (VEEG) were abnormal in 127 patients and in 62 patients clinical seizures were captured. Global developmental delay was presented in 122 patients. Epilepsy syndromes were diagnosed in 59 patients. Thirteen patients were diagnosed as Ohtahara syndrome (OS), 9 as epilepsy of infancy with migrating focal seizures (EIMFS), 17 as West syndrome (WS), 4 as OS developed to WS, 9 as benign neonatal epilepsy (BNE), 2 as benign familiar neonatal-infantile epilepsy (BFNIE), 2 as benign infantile epilepsy (BIE) and 3 as benign familial infantile epilepsy (BFIE). Sixty-seven patients were diagnosed as unclassified early infantile epileptic encephalopathy (EIEE), 13 patients could not be diagnosed as any epilepsy syndrome, and 2 patients were diagnosed as pyridoxine-dependent epilepsy. Forty-six patients had abnormal neuroimaging including cortical atrophy, corpus callosum dysplasia and cerebellar atrophy, involving 19 genes.Conclusions:Neonatal-onset epilepsy is related to many different genes. Seizure onset age of most patients is within one week after birth. Focal seizures and epileptic spasms are more common. Some patients show abnormal neuroimaging.
Neonatal seizures: the overlap between diagnosis of metabolic disorders and structural abnormalities. Case report

Alessandra Freitas,Erasmo B Casella,Marcelo Valente,Carlos A Buchpiguel,Kette D R Valente

DOI: https://doi.org/10.1590/s0004-282x2003000300029

Abstract:Inborn metabolic errors (IME) and cortical developmental malformations are uncommon etiologies of neonatal seizures, however they may represent treatable causes of refractory epilepsy and for this reason must be considered as possible etiological factors. This case report aims to demonstrate the importance of neuroimaging studies in one patient with neonatal seizures, even when there are clues pointing to a metabolic disorder. Case report: A previously healthy 14 day-old child started presenting reiterated focal motor seizures (FMS) which evolved to status epilepticus. Exams showed high serum levels of ammonia and no other abnormalities. A metabolic investigation was conducted with normal results. During follow-up, the patient presented developmental delay and left side hemiparesia. Seizures remained controlled with anti-epileptic drugs for four months, followed by relapse with repetitive FMS on the left side. Temporary improvement was obtained with anti-epileptic drug adjustment. At the age of 6 months, during a new episode of status epilepticus, high ammonia levels were detected. Other metabolic exams remained normal. The child was referred to a video-electroencephalographic monitoring and continuous epileptiform discharges were recorded over the right parasagittal and midline regions, with predominance over the posterior quadrant. A new neuroimaging study was performed and displayed a malformation of cortical development. Our case illustrates that because newborns are prone to present metabolic disarrangement, an unbalance such as hyperammonemia may be a consequence of acute events and conduct to a misdiagnosis of IME.
[BIOINFORMATICS COMPARISON OF HUMAN AND PLANT PHOSPHATOMES].

D. Samofalova,P. Karpov,Y. Blume

2015-07-01

Abstract:The study presents the results of bioinformatic comparison of protein phosphatases from higher plants and human phosphatom (150 sequences). Based on sequence and profile comparison with known catalytic domains, 204 plant homologues from Physcomitrella patens and Arabidopsis thaliana where selected. Clustering of joint group of plant and mammalian protein phosphatases revealed fundamental differences in plant and human phosphatomes. At the same time, it was shown significant differences in the set of protein phosphatases in P. patens, A. thaliana, and such monocots as Orysa saliva and Zea mays.
Symptomatic seizures in preterm newborns: a review on clinical features and prognosis

Carlotta Spagnoli,Raffaele Falsaperla,Michela Deolmi,Giovanni Corsello,Francesco Pisani

DOI: https://doi.org/10.1186/s13052-018-0573-y

IF: 3.288

2018-11-01

Italian Journal of Pediatrics

Abstract:Neonatal seizures are the most common neurological event in newborns, showing higher prevalence in preterm than in full-term infants. In the majority of cases they represent acute symptomatic phenomena, the main etiologies being intraventricular haemorrhage, hypoxic-ischemic encephalopathy, central nervous system infections and transient metabolic derangements.Current definition of neonatal seizures requires detection of paroxysmal EEG-changes, and in preterm newborns the incidence of electrographic-only seizures seems to be particularly high, further stressing the crucial role of electroencephalogram monitoring in this population. Imaging work-up includes an integration of serial cranial ultrasound and brain magnetic resonance at term-equivalent age. Unfavourable outcomes following seizures in preterm infants include death, neurodevelopmental impairment, epilepsy, cerebral palsy, hearing and visual impairment. As experimental evidence suggests a detrimental role of seizures per se in determining subsequent outcome, they should be promptly treated with the aim to reduce seizure burden and long-term disabilities. However, neonatal seizures show low response to conventional anticonvulsant drugs, and this is even more evident in preterm newborns, due to intrinsic developmental factors. As a consequence, as literature does not provide any specific guidelines, due to the lack of robust evidence, off-label medications are often administered in clinical practice.

pediatrics
Harry E. Bacon oration. Evolution of surgical management of ulcerative colitis.

I. Khubchandani

1989-11-01

Diseases of the Colon & Rectum

Abstract:
Main Electroclinic Syndromes of The Infant

Bruno César Fernandes,Raquel Borges de Barros Primo,Anny Karoliny das Chagas Bandeira,Mariella Rodrigues da Silva,Carolina Calixto de Souza Andrade,Alan Márcio de Brito Araújo,Vanessa Rodrigues Moraes Delgado,Kaio Guilherme Campos Paulo Ikeda,Michelle Katiuscia Melo Mota,Valeska Lopes Pereira,Ubirajara Medeiros Costa,Eusania Marcia Nascimento,Carmen Célia Neves de Souza,Rodrigo Alexandre Teixeira,Fátima Aparecida Balbino,Maria De Jesus Costa Salgado,Nayara Andrade de Oliveira

DOI: https://doi.org/10.31686/ijier.vol10.iss10.3965

2022-10-01

International Journal for Innovation Education and Research

Abstract:An electroclinic syndrome (also known as epileptic syndrome) consists of a set of characteristics that associate with seizures, characteristics of electroencephalography and imaging that tend to occur together. Among them is a group that affects infants, usually having a genetic etiology. Objective: to carry out a literature review on the most common types of infant electroclinical syndromes, describing their main characteristics. Methodology: This is a narrative review of the literature of articles published between 2005 and 2020, in Portuguese and English. The research was carried out in December 2020. The following descriptors were used to search for the articles: Electroclinical syndromes. Epilepsy. Infant. Results: Through the research carried out, 12 scientific articles were selected, nine of them in English and three in Portuguese. Conclusion: The study identified 7 common electroclinical syndromes in infants and made it possible to conclude that knowledge of the clinical profile, types of crises and characteristics of the electroencephalography of the disease phenotype associated with the specific mutation can help improve the accuracy and management of the diagnosis of electroclinical syndromes.
Miniaturization Techniques of Substrate Integrated Waveguide Circuits

Yan Ding,K. Wu

DOI: https://doi.org/10.1109/IMWS.2008.4782262

2008-12-01

Abstract:Substrate integrated waveguide (SIW) has become popular and it has widely been used in microwave and millimeter wave circuit and system designs. Compared to other planar transmission lines, the geometrical dimension, in particular, the width of an SIW is much larger, which depends on the operating frequency and substrate material. Therefore, an effective SIW miniaturization is required for developing a high-density integration in circuit design. In this paper, three miniaturization techniques of SIW circuits are discussed in order to achieve a high compression ratio. A group of SIW transmission lines based on these miniaturization techniques are analyzed and their propagation constants and quality factors are extracted for comparison.
Multifactorial pathogenesis of neonatal seizures--relationships to the benign partial epilepsies

H Doose,K Koudriavtseva,B A Neubauer

Abstract:Elevated incidence of neonatal seizures (NS) in children with idiopathic partial epilepsies, as well as reports on the transition of NS into benign partial epilepsy, point to pathogenetic relationships between these conditions. Further insight into the nature of these relationships can be expected only from NS patients with long-term follow-up, which includes the age range of maximum manifestation of subsequent seizures or epilepsies (SSE), and age-dependent genetic EEG traits. A sample of such cases will necessarily be selected and thus prohibit any quantitative inferences regarding the incidence of SSE and special EEG characteristics. Nevertheless, the data provide new aspects with regard to a possibly multifactorial pathogenesis of NS and SSE. Children in the present study were selected applying the following inclusion criteria: cerebral seizures during the first 14 days of life; follow up of more than two years with at least two EEG recordings beyond the age of two. Children with metabolic NS or subsequent West syndrome were not included. Seventy-six cases were confirmed, 42 with SSE, 34 without. The incidence of EEG symptoms of a generalized genetic seizure liability (theta rhythms, generalized spikes and waves, photoparoxysmal response) was significantly elevated, equally in children with and without SSE. Beyond the age of two years, 50% of the probands had focal sharp waves foci characteristic of idiopathic partial epilepsy (e.g. rolandic epilepsy). Among SSE, febrile convulsions and partial epilepsies with benign course dominated. Idiopathic generalized epilepsies were not observed. These findings indicate that in a certain proportion of cases, NS have genetic factors in common with idiopathic partial epilepsies. Quantitative representative data cannot be obtained to determine the incidence of such pathogenetic mechanisms in NS and SSE.
Neonatal Seizures and Associated Neurobehavioral Profiles in Preschool Age Children

Allyssa M. Mattes,Renée A. Shellhaas,Hannah C. Glass,Julie Sturza,Stephanie Rau,Monica Lemmon,Elizabeth E. Rogers,Adam Numis,Janet S. Soul,Maddison Berl,Courtney J. Wusthoff,Catherine J. Chu,Shavonne L. Massey,Cameron Thomas,Linda S. Franck,Charles E. McCulloch,Guilia Benedetti,Justin Means,Katie Means,Tayyba Anwar,Jennifer C. Gidley Larson

DOI: https://doi.org/10.1016/j.pediatrneurol.2024.11.008

IF: 4.21

2024-12-01

Pediatric Neurology

Abstract:Background Neonatal seizures are common with acute brain injury. Up to 25% of survivors develop post-neonatal epilepsy. We hypothesized post-neonatal epilepsy diagnosed by age 24-months would increase risk for early markers of neurobehavioral disorders than acute provoked neonatal seizures alone. Methods Neonates with acute provoked seizures born 7/2015-3/2018 enrolled at 9 Neonatal Seizure Registry sites. Composite scores from parent-completed standardized ratings assessed Adaptive, Social, Externalizing, Internalizing, Self-Regulation, and Sensory Seeking domains. Linear regression demonstrated relationships between composite scores for children who developed post-neonatal epilepsy compared with those who did not. Results were adjusted for seizure etiology, sex, gestational age, and cerebral palsy (CP) severity. Results 151 children ( n =20, 13% with post-neonatal epilepsy), 4.1 years median age participated. Children with epilepsy had impaired adaptive (Cohen's d = 1.62, p<.0001), social (Cohen's d = 0.86, p=0.004), and executive functioning (Cohen's d = 0.56, p=0.06) compared to children without epilepsy. Mean neurobehavioral scores for children without epilepsy were within normative average range. Risk for impairment among children with epilepsy persisted after adjusting for neonatal seizure etiology, sex, and gestational age, but not when adjusting for CP severity. Conclusions In this cohort of survivors of provoked neonatal seizures, there was higher incidence of adverse neurobehavioral outcomes among preschool children diagnosed with post-neonatal epilepsy compared with those without epilepsy. CP severity was associated with greater impairment, results also suggest that epilepsy is an independent predictor of adaptive functioning. Children with post-neonatal epilepsy should be screened for neurobehavioral problems to facilitate early identification and developmental support.

pediatrics,clinical neurology
Clinical and electroencephalography characteristics of 45 patients with neonatal seizures

Luying Li,Yu Deng,Jin Chen,Lingling Xie,Xinghui Lan,Yue Hu,Siqi Hong,Li Jiang

DOI: https://doi.org/10.1016/j.neucli.2023.102886

IF: 3.1

2023-02-01

Neurophysiologie Clinique

Abstract:OBJECTIVES: The aim of our study was to retrospectively research the semiology of neonatal seizures (NSs) based on the 2021 classification scheme of the International League Against Epilepsy, and the relationship between etiology and electroclinical features.METHODS: Patients admitted to Children's Hospital of Chongqing Medical University from May 1, 2020 to March 30, 2022 and diagnosed with NSs were included to retrospectively investigate the etiology, seizure characteristics, prognosis, and ictal and interictal video electroencephalography (EEG) characteristics.RESULTS: Of the 45 patients, 73.3% had definite etiology. Twenty-seven patients had electro-clinical seizures, of which two had both electro-clinical and electrographic-only seizures. Electrographic-only seizures were reported in 18 patients. The tonic, clonic, and electrographic-only seizures were associated with various etiologies. Both tonic and clonic seizures occurred in acute symptomatic seizures and were associated with neonatal epilepsy. 50% of tonic seizures were related to genetic factors. Among the clonic seizures, 50.0% occurred in acute symptomatic seizures. Epileptic spasms always indicated neonatal epilepsy. There were few patients who experienced automatisms and sequential seizures, and these two seizure types were associated with brain malformation and genetic factors, respectively. Patients with a normal interictal EEG had acute symptomatic seizures. whereas the interictal EEG of patients with neonatal epilepsy mainly showed burst-suppression or multifocal discharges. The ictal EEG recordings were related to seizure semiology.CONCLUSION: Seizure semiology and video EEG are suggestive of potential causes but do not provide a definite etiology.

neurosciences,clinical neurology,physiology
Why we urgently need improved seizure and epilepsy therapies for children and neonates

Ronit M Pressler,Lieven Lagae

DOI: https://doi.org/10.1016/j.neuropharm.2019.107854

IF: 5.273

2020-06-15

Neuropharmacology

Abstract:In contrast to epilepsy in adolescents and adults, neonatal seizures and early onset epilepsy poses unique challenges with significant repercussion for treatment choices. Most importantly, high seizure burden and epileptic encephalopathy are associated with developmental, behavioural and cognitive problems. The causes are multifactorial and include etiology, seizure burden, epileptic encephalopathy, but also antiseizure medication. In contrast to adults and older children only very few drugs have been licenced for infants and neonates, and after a long delay. Very recently, extrapolation of adult data has become possible as a path to speed up drug development for younger children but this is not necessarily possible for infants and neonates. With the advances in understanding the molecular basis of many epilepsies, targeted therapies become available, for example for KCNQ2 mutation related epilepsies, Dravet syndrome or tuberous sclerosis complex. Drug trials in neonates are particularly challenging because of their inconspicuous clinical presentation, the need for continuous EEG monitoring, high co-morbidity, and poor response to antiepileptic drugs. There is an urgent need for development of new drugs, evaluation of safety and efficacy of current antiseizure drugs, as well as for national policies and guidelines for the management of seizures and epilepsy in neonates and infants. This article is part of the special issue entitled 'New Epilepsy Therapies for the 21st Century - From Antiseizure Drugs to Prevention, Modification and Cure of Epilepsy'.
Interpretation for the International League Against Epilepsy task force on neonatal seizure expert (2021)

程国强,张鹏,周文浩,许艳

DOI: https://doi.org/10.3760/cma.j.cn101070-20210811-00957

2021-01-01

Abstract:Seizure is the most common neurological critical disease in the neonatal period, most of which is symptomatic.Seizure is usually caused by acute brain injury, and only electrical seizure is more commonly seen.Neonatal seizures are not easy to be included in the epilepsy classification established by the International League Against Epilepsy (ILAE). As a result, a Neonatal Seizures Task Force was established by the ILAE to develop a modification of the 2017 ILAE classification of seizures and epilepsies.The neonatal classification framework emphasizes the role of electroencephalography (EEG) in the diagnosis of neonatal seizure, which includes a classification of seizure types especially in newborns.The type of seizure in adults and older children mainly depends on clinical characteristics, while many newborns only have electric seizures.Therefore, electric seizures are included in the classification scheme.Clinical events without corresponding EEG changes are not included.Neonatal seizures are all focal seizures, and focal and generalized seizures are unnecessarily to be categorized.Seizures can be classified by abnormal motor episodes (automata, clonic, myoclonic, tonic) and non-motor episodes (autonomic, behavioral changes) or sequential presentation.The new classification can be used to more specifically classify neonatal seizures.
Epilepsies with onset during the first year of life: A prospective study on syndromes, etiologies, and outcomes

Henna Jonsson,Eija Gaily,Susanna Stjerna,Tarja Joensuu,Mridul Johari,Anna-Elina Lehesjoki,Tarja Linnankivi

DOI: https://doi.org/10.1002/epi4.12966

Epilepsia Open

Abstract:Objective: Infantile seizures cause great concern for both doctors and parents. In addition to modern neuroimaging and genetics, clinical tools helpful in predicting the course of the disease are needed. We prospectively studied the incidence, electroclinical characteristics and etiologies of epilepsy syndromes with onset before the age of 12 months and looked for prognostic determinants of outcome by age 24 months. Methods: From February 2017 through May 2019, we recruited all eligible infants diagnosed with epilepsy at our unit. Data on electroclinical studies, genetic investigations and drug response were gathered prospectively. The infants were given a structured neurological examination (Hammersmith Infantile Neurological examination [HINE] and Griffiths scales) at predetermined intervals until age 24 months at which age neurocognitive evaluation with Bayley scales was performed. Results: Included were 60 infants (27 female). The mean onset age of epilepsy was 5.3 (±2.5 standard deviation) months. The incidence of epilepsy in the population-based cohort was 131 (95% confidence interval 99-172)/100 000. Epilepsy syndrome was identified in 80% and etiology in 58% of infants. Self-limited infantile epilepsy was the second most common syndrome (incidence 18/100 000) after infantile epileptic spasms syndrome. PRRT2 was the most common monogenic cause. At age 24 months, 37% of the infants had drug-resistant epilepsy (DRE) and half had a global developmental delay (GDD). Abnormal first HINE was the strongest predictor of GDD, followed by DRE and identified etiology. DRE was associated with structural etiology and GDD. Those with normal first HINE and good response to treatment had favorable outcomes, irrespective of the identified etiology. Significance: Our results support a high incidence of self-limited epilepsy in infancy and PRRT2 as the genetic cause in the first year of life. Notwithstanding the advances in etiological discovery, we want to highlight the importance of clinical evaluation as standardized neurological examination with HINE proved a valuable tool in prognostication. Plain language summary: One in every 700-800 babies develop epilepsy within the first year after birth. Our study identified an epilepsy syndrome in 80% and the cause of epilepsy in 60% of the participants. By age 2 years, over one-third of the children still experienced seizures, and almost half faced significant developmental delay. Structural brain abnormalities increased the likelihood of difficult epilepsy and developmental challenges. Babies whose epilepsy was caused by a gene defect varied widely in development and response to medications. Babies with normal neurological examination at first visit, especially if their seizures stopped quickly, had favorable development.
Metabolic epilepsies: approaches to a diagnostic challenge

Sylvia Stöckler-Ipsiroglu,Barbara Plecko

Abstract:Although inborn errors of metabolism (IEM) are a relatively rare cause of epilepsy in children, their diagnosis is important with respect to treatment, prognosis and genetic counselling. In addition to seizures and epilepsy, IEM may produce a complex clinical picture in which epilepsy is only one of the various neurologic manifestations including developmental delay/regression, mental retardation, movement disorders, micro-/macrocephaly, as well as cerebral grey and white matter changes. Dysmorphic features and cerebral dysgenesis may also be part of a metabolic epilepsy syndrome (e.g. disorders of peroxisomal biogenesis, glutaric aciduria type 2, pyruvate dehydrogenease complex deficiency). Metabolic epilepsies may dominate the clinical presentation (e.g. pyridoxine dependent epilepsy) or may precede further neurologic deterioration (e.g. neuronal ceroid lipofuscinosis) and additional organ involvement (e.g. liver failure in Alpers (POLG1) disease). Metabolic epilepsies often present with myoclonic seizures (e.g. Gaucher Disease type 3, mitochondrial syndromes) and, as a rule, patients presenting with predominantly myoclonic seizures should be carefully investigated for these types of metabolic epilepsies. Patients with very early onset of epilepsy are considered at high risk for an underlying IEM as well. In this review we present an overview of metabolic epilepsies based on various criteria such as treatability, age of onset, seizure type, and pathogenetic background. Exemplary disorders will be described in more detail including cerebral glucose transporter (GLUT1) deficiency, pyridoxine dependent epilepsy, neuronal ceroid lipofuscinosis, cathepsin D deficiency, Alpers syndrome (POLG deficiency), and guanidinoacetate methyltransferase (GAMT) deficiency.

[A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors and metabolic syndrome].

Neonatal seizures and status epilepticus

New treatment paradigms in neonatal metabolic epilepsies

Developmental and epileptic encephalopathies

Recent Advances in the Diagnosis and Treatment of Neonatal Seizures

ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions

Neonatal seizures as onset of Inborn Errors of Metabolism (IEMs): from diagnosis to treatment. A systematic review

Genotypes and Clinical Features of Neonatal-Onset Genetic Epilepsy in 141 Patients

Neonatal seizures: the overlap between diagnosis of metabolic disorders and structural abnormalities. Case report

[BIOINFORMATICS COMPARISON OF HUMAN AND PLANT PHOSPHATOMES].

Symptomatic seizures in preterm newborns: a review on clinical features and prognosis

Harry E. Bacon oration. Evolution of surgical management of ulcerative colitis.

Main Electroclinic Syndromes of The Infant

Miniaturization Techniques of Substrate Integrated Waveguide Circuits

Multifactorial pathogenesis of neonatal seizures--relationships to the benign partial epilepsies

Neonatal Seizures and Associated Neurobehavioral Profiles in Preschool Age Children

Clinical and electroencephalography characteristics of 45 patients with neonatal seizures

Why we urgently need improved seizure and epilepsy therapies for children and neonates

Interpretation for the International League Against Epilepsy task force on neonatal seizure expert (2021)

Epilepsies with onset during the first year of life: A prospective study on syndromes, etiologies, and outcomes

Metabolic epilepsies: approaches to a diagnostic challenge